TDC
HQY icon

Thompson Davis & Co’s HealthEquity HQY Stock Holding History

Thompson Davis & Co’s Portfolio HQY Stock Details HQY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-125
Closed -$6K – 859
2017
Q3 		$6K Sell
125
-475
-79% -$22.1K 0.01% 812
2017
Q2 		$30K Buy
600
+100
+20% +$4.68K 0.05% 333
2017
Q1 		$21K Buy
+500
New +$22.1K 0.03% 475

Other funds holding HQY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thompson Davis & Co's HQY Position: Q4 2017 in Review

Thompson Davis & Co sold out of HealthEquity (HQY) in Q4 2017, closing a stake of 125 shares — an estimated $6K sold.

Thompson Davis & Co first reported a position in HQY in Q1 2017 and held it in 3 quarters. The position peaked at $30K in Q2 2017. 235 funds tracked by Wall St. Rank hold HQY as of Q4 2017.

  • Thompson Davis & Co reported no remaining HealthEquity position as of Q4 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 125 HealthEquity shares in Q4 2017, an estimated $6K.
  • Thompson Davis & Co first reported a position in HealthEquity in Q1 2017 and held it in 3 quarters.
  • Thompson Davis & Co's HealthEquity position peaked at $30K in Q2 2017.
  • 235 funds tracked by Wall St. Rank held HealthEquity as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.